跳至主要内容
临床试验/NCT05859581
NCT05859581招募中不适用

To Explore the Value of Colon MRI in Assessing the Status of Retroperitoneal Resection Margin Following Beyond Complete Mesocolic Excision Surgery for Advanced Colon Cancer

Peking University Cancer Hospital & Institute1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2023年4月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
29
试验地点
1
主要终点
Coincidence rate with pathological result

研究概览

简要总结

The goal of this clinical trial is to explore the value of colon MRI in assessing the status of retroperitoneal resection margin (RPRM) for advanced colon cancer.

The main questions it aims to answer are:

  • Concordance between MRI suspected RPRM positive and pathologically confirmed positive.
  • Can RPRM-positive patients undergo beyond complete mesocolic excision (CME) surgery in order to achieve R0 resection?

Participants will undergo colon MRI examination and once MRI suspects RPRM positive, they will receive beyond CME surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • primary colon adenocarcinoma confirmed by biopsy
  • preoperative CT suspecting retroperitoneal resection margin (RPRM) positive
  • received colon MRI scan
  • underwent beyond complete mesocolic excision surgery
  • sufficient clinical and pathological results

排除标准

  • combined with other malignant tumors
  • simultaneous distant metastasis
  • definite invaded other organs or structures (T4b tumors)

结局指标

主要结局

Coincidence rate with pathological result

时间窗: within 2 weeks after surgery

Coincidence rate between MRI diagnosed retroperitoneal resection margin and pathologically confirmed positive

次要结局

未报告次要终点

研究者

发起方
Peking University Cancer Hospital & Institute
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验